Planning controlled clinical trials on the basis of descriptive data analysis
- 1 May 1991
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 10 (5) , 777-795
- https://doi.org/10.1002/sim.4780100513
Abstract
In controlled clinical trials the problem of multiplicity of desired inferential statements finds attention at an increasing rate. In this paper the previously proposed concept of Descriptive Data Analysis (DDA), situated between Confirmatory and Exploratory Data Analysis, is applied to the planning aspects of controlled trials for which the problem of multiplicity exists. The (non-Bayesian) DDA planning concept should provide the investigator with tools to draw final conclusions from data of several variables possibly observed at several time points in possibly several groups of subjects by combining his pre-trial medical experience with descriptive inferential statements (confidence intervals and test results) at nominal significance levels. DDA also provides for confirmatory statements concerning individual null hypotheses and partially global hypotheses.Keywords
This publication has 15 references indexed in Scilit:
- A sharper Bonferroni procedure for multiple tests of significanceBiometrika, 1988
- SUBGROUP ANALYSISThe Lancet, 1988
- A stagewise rejective multiple test procedure based on a modified Bonferroni testBiometrika, 1988
- Statistical Problems in the Reporting of Clinical TrialsNew England Journal of Medicine, 1987
- An improved Bonferroni procedure for multiple tests of significanceBiometrika, 1986
- Problems of repeated significance testingControlled Clinical Trials, 1981
- Das maximale signifikanzniveau des Tests: “LehneH o ab, wennk untern gegebenen tests zur ablehnung führen”Metrika, 1978
- Best Possible Inequalities for the Probability of a Logical Function of EventsThe American Mathematical Monthly, 1965
- A Multiple Comparison Procedure for Comparing Several Treatments with a ControlJournal of the American Statistical Association, 1955